Implications of Fragment-Based Drug Discovery in Tuberculosis and HIV.

Mallakuntla, Mohan Krishna; Togre, Namdev S; Santos, Destiny B; Tiwari, Sangeeta

Mallakuntla, Mohan Krishna; Togre, Namdev S; Santos, Destiny B; Tiwari, Sangeeta.

Afiliação

Mallakuntla MK; Department of Biological Sciences & Border Biomedical Research Centre, University of Texas at El Paso, El Paso, TX 79968, USA.
Togre NS; Department of Biological Sciences & Border Biomedical Research Centre, University of Texas at El Paso, El Paso, TX 79968, USA.
Santos DB; Department of Biological Sciences & Border Biomedical Research Centre, University of Texas at El Paso, El Paso, TX 79968, USA.
Tiwari S; Department of Biological Sciences & Border Biomedical Research Centre, University of Texas at El Paso, El Paso, TX 79968, USA.

Pharmaceuticals (Basel) ; 15(11)2022 Nov 15.

Article em En | MEDLINE | ID: mdl-36422545

Palavras-chave

HIV; drug-discovery; fragment-based drug design; mycobacterium tuberculosis; structure-based drug design

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google